Back to search

Article

Meta-analysis of genetic mapping studies in mice reveals candidate epilepsy modifier genes that are outside the current drug development landscape

2025-08-21

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objective</h4> Despite decades of development in anti-seizure medications, approximately 30% of individuals remain refractory to all treatments, and none of the existing therapies are disease-modifying. Identifying targets outside the current preclinical paradigm is critically important. This study aimed to characterize the landscape of current epilepsy treatments at the level of gene inter...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a3a405a2-77c3-5d3e-8a47-8d35f9358e8c
DOI
10.1101/2025.08.15.669922
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Meta-analysis of genetic mapping studies in mice reveals candidate epilepsy modifier genes that are outside the current drug development landscapeDOI 10.1101/2025.08.15.669922
Select a neighboring publication to make it the new centre.